Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Evogene Ltd. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 31 | +6 |
| Shares | 1.46M | 117.0K | 1.09M | −247.8K (−18.5%) |
| Value | $1.21M | $96.0K | $753.9K | −$358.3K (−32.2%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Evogene Ltd. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Joel Isaacson & Co., LLC | 30,000 | $21.0K | 0.00% |
| Rockefeller Capital Management L.P. | 20,000 | $14.0K | 0.00% |
| Susquehanna International Group, LLP | 14,352 | $10.0K | 0.00% |
| Linscomb & Williams, Inc. | 10,000 | $7.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 2,900 | $2.03K | 0.00% |
| Coppell Advisory Solutions LLC | 60 | $42 | 0.00% |
| Coppell Advisory Solutions Corp. | 60 | $42 | 0.00% |
| JPMorgan Chase & Co | 137 | $0 | 0.00% |
| Creative Capital Management Investments LLC | 200 | $0 | 0.00% |
Sold out (3)
Institutions that held Evogene Ltd. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Senvest Management, LLC | 230,606 | $191.0K |
| Virtu Financial LLC | 15,290 | $13.0K |
| We Are One Seven, LLC | 14,840 | $12.0K |
Not filed for Q4 2022 yet (1)
Institutions that held Evogene Ltd. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Eidelman Virant Capital | 117,000 | $96.0K |